The primary objective of this study is to assess the ability of the PHP \& HPHP to detect newly diagnosed non treated Chorodial neovascularization (CNV) lesion associate with advanced age related Macular Degeneration (AMD) and differentiate them from Early/intermediate/GA AMD
the study is prospective, multi-center, comparative The PHP is a class I FDA approved Device ( K050350 )
Study Type
OBSERVATIONAL
Enrollment
336
Ha'emek Hospital
Afula, Israel
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.